Home NDC 50090-1758 Typhim Vi
Product NDC 50090-1758
11-digit product format 500901758
Labeler code 50090
Product ID 50090-1758_05589cd5-7687-4e35-a1a3-712de16d0583
Type VACCINE
Nonproprietary name SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Dosage form INJECTION, SOLUTION
Route INTRAMUSCULAR
Labeler A-S Medication Solutions
Application BLA103936
Marketing category BLA
Marketing start 1994-11-28
Marketing end 0000-00-00
Substance SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Active strength 25 ug/.5mL
Pharmacologic classes Inactivated Salmonella Typhi Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Vaccines, Typhoid [CS],Polysaccharides, Bacterial [CS]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50090-1758-0 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50090-1758-0 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 50090-1758-0 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 50090-1758-0 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 50090-1758-0 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 50090-1758-0 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 50090-1758-0 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 50090-1758-0 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 50090-1758-0 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-1758-0 TYPHIM VI 1 in 1 PACKAGE INJECTION, SOLUTION 1 19 50090-1758-9 TYPHIM VI 10 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 10 19
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-1758 TYPHIM VI (SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] 19 Legacy NDC, 2 package rows 20231023_21b75f1d-1cda-49e5-8176-cc23827824f3.zip
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103936 Typhim Vi Typhoid Vi Polysaccharide Vaccine 351(a) Rx 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-1758-0 50090175800 1 VIAL, MULTI-DOSE in 1 PACKAGE (50090-1758-0) > 10 mL in 1 VIAL, MULTI-DOSE (50090-1758-9) 1994-11-28 0000-00-00 No No Current 50090-1758-9 50090175809 10 mL in 1 VIAL, MULTI-DOSE 10 ml Historical